This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,977.86 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the medication Creon DR. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This award appears to be a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.
Generated 3/19/25, 9:52 AM